Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

NIH offers licenses for conjugate vaccine

Jan. 23, 1997

Anti-CD11a MAb enters clinical trials for second indication

Jan. 22, 1997

Aquila adjuvant shows promise as component of malaria vaccine

Jan. 20, 1997

Anti-IL-2 monoclonal antibody described by Ajinomoto

Jan. 20, 1997

Obstacles to tolerance induction in the treatment of autoimmune disease

Jan. 17, 1997

Betafectin clinical update

Jan. 13, 1997

AutoImmune initiates clinical trials in transplant rejection

Jan. 13, 1997

Kimmel Cancer Center's immunological disease therapy progress

Jan. 10, 1997

Korean researchers report new immunosuppressant from natural source

Jan. 10, 1997

SKB/WRAIR malaria vaccine shown effective in clinical challenge trial

Jan. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...